Drug intelligence / Profile preview

mfgm-rutf

Development stage
Unknown
Lead developer
Arla Foods Ingredients
Modality
Recombinant Proteins and Enzymes, Peptides, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

MFGM-RUTF is a specialized formulation of ready-to-use therapeutic food (RUTF) enhanced with milk fat globule membrane (MFGM), currently under clinical investigation for the treatment of children with severe acute malnutrition (SAM). Standard RUTF typically consists of peanut paste, sugar, vegetable oil, and skim milk powder; however, it lacks certain bioactive lipids and proteins found in mammalian milk that are critical for neurodevelopment. MFGM-RUTF incorporates an MFGM-containing whey protein/fat concentrate, providing essential sphingolipids (such as sphingomyelin), cholesterol, and phospholipids (including phosphatidylcholine and phosphatidylethanolamine). Additionally, because MFGM acts as a natural emulsifier, this formulation allows for the omission of synthetic hydrogenated vegetable oil emulsifiers, which may potentially improve gut barrier healing in malnourished children. The primary goals of MFGM-RUTF therapy are to improve neurodevelopmental recovery and reduce the incidence of poor clinical outcomes, such as death or hospitalization, compared to standard skim milk-based RUTF.

Other names
Milk Fat Globule Membrane-Enhanced Ready-to-Use Therapeutic FoodMFGM-RUTF

Beyond the preview

Go deeper on mfgm-rutf.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mfgm-rutf.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call